Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAMIVUDINE vs LANADELUMAB-FLYO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAMIVUDINE vs LANADELUMAB-FLYO: Safety Overview

Metric LAMIVUDINE LANADELUMAB-FLYO
Total FAERS Reports 16,685 1,493
Deaths Reported 1,838 35
Death Rate 11.0% 2.3%
Hospitalizations 3,442 427
Average Patient Age 43.0 yrs 45.0 yrs
% Female Patients 35.2% 77.3%
FDA Approval Date Apr 19, 2018 N/A
Manufacturer Aurobindo Pharma Limited N/A
Route ORAL N/A
Marketing Status Prescription Prescription